In-Depth Matrisome and Glycoproteomic Analysis of Human Brain Glioblastoma Versus Control Tissue
Open Access
- 23 February 2022
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 21 (4) , 100216
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01GM133963)
- National Institutes of Health (P41GM104603)
- National Institutes of Health (R24GM134210)
- National Institutes of Health (U01CA168878)
- National Institutes of Health (U01CA221234)
This publication has 74 references indexed in Scilit:
- A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology, 2012
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular MatricesMolecular & Cellular Proteomics, 2012
- Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastomaActa Neuropathologica, 2011
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Reduced Expression of the Hyaluronan and Proteoglycan Link Proteins in Malignant GliomasJournal of Biological Chemistry, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signalingOncogene, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- A Novel Membrane-associated Glycovariant of BEHAB/Brevican Is Up-regulated during Rat Brain Development and in a Rat Model of Invasive GliomaJournal of Biological Chemistry, 2003